Seyednasrollah, Fatemeh <br/><br/>
Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models.  [electronic resource] 

 -  European urology  09 2017 
 - e70-e71 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2017.04.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Male<br/>Prognosis<br/>Prostatic Neoplasms, Castration-Resistant